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A case of recurrent breast cancer diagnosed from
symptomatic metastasis to bladder
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ABSTRACT
A woman living in the United States has approximately a one in eight chance of developing breast cancer within her lifetime. The main cause of death associated with breast
cancer is from metastatic spread of the disease, with the most frequent sites of spread
being the bone, brain, and lungs. The urinary bladder is an uncommon site of metastasis, rarely reported on in the literature. In this report, we present a case of recurrent
metastatic breast cancer found in the urinary bladder with no other sites of metastatic
spread. A thorough history should be obtained in all patients, and in patients with a
previous history of cancer, reoccurrence and distant spread should be kept as a differential diagnosis.

Author affiliations are
listed at the end of this
article.
Correspondence to:
Andrew J. Weaver
Marshall University
Joan C. Edwards
School of Medicine

weaveran@marshall.edu

KEYWORDS

Metastatic Breast Carcinoma, Hematuria

The patient is a 61-year-old female with a history of
locally advanced ER/PR+, HER-2 negative breast cancer diagnosed in September 2002. At the time of her
diagnosis, she underwent neoadjuvant chemotherapy, followed by a mastectomy with sentinel lymph
node biopsy where five of eight lymph nodes were
found to be positive. She was treated with adjuvant
Taxotere for four cycles, after which she received radiation to her chest wall. She completed her radiation
therapy in August 2003 and received tamoxifen until
2009. At that time, she was switched to Femara and
went on to complete more than five years of therapy.
During her therapy, she was under regular surveillance, which included mammograms and clinic visits
that showed no findings of recurrent disease.
Of note, this patient had a past medical history of
asthma, diabetes type II, hyperlipidemia, hypertension, osteoarthritis, and hypothyroidism. She reported no tobacco or drug use and only mild alcohol
consumption. Both parents are alive, and there is no
known family history of breast cancer.
In April 2019, she presented with lower abdominal pain and hematuria for which she underwent a
cystoscopy. The examination showed a single large
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sessile neoplasm in the upper dome region of the
bladder. Transurethral resection of the bladder tumor
was completed with pathology findings of ER/PR +
HER-2 negative breast carcinoma. A systemic workup,
which included CT scans of the chest, abdomen, and
pelvis, and a bone scan were completed. Findings
included a thyroid nodule, which was negative for
malignancy on fine-needle aspiration, and a palpable
lymph node in her right inguinal region, which was
biopsied and also negative.
The patient was started on daily letrozole and cycles
of palbociclib. She continued on calcium and vitamin D supplements. She tolerated this regimen well.
The most recent mammogram of the left breast was
negative.
DISCUSSION
Secondary tumors found in the bladder, such as
metastasis, are rare and account for only two percent
of bladder tumors.1 Most of these are from direct invasion from adjacent structures in the pelvis.2 Due to
the rarity of metastasis from the breast to the bladder,
screening for bladder metastasis is typically triggered
only by symptoms such as lower abdominal pain or
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hematuria, which is how our patient presented. Even
more rare are findings of metastasis incidentally without symptoms.3
Differentiating between primary bladder neoplasm
and metastasis requires biopsy and pathological
examination. One would expect homogenous expression of ER/PR receptors between the primary
neoplasm in the breast and the metastasis. However,
heterogenic expression between the primary breast
tumor and the metastatic lesion is not uncommon,
with some studies showing 20 to 40 percent of
patients demonstrating discordance.4 This makes for
an important distinction between primary versus
metastatic neoplasms of the bladder and possible
treatment modalities.
Another point to consider is how breast cancer can
metastasize to the bladder with no local involvement.
Previously, it was believed that metastasis to the bladder occurred through the extension of retroperitoneal masses. However, another proposed mechanism
occurs through venous emboli.5 The theory of metastatic emboli from a primary source could account for
both solitary bladder involvement and the presence
of metastasis in the absence of gross disease reoccurrence.
This leads us to consider if there is enough evidence
to promote routine screening for bladder metastasis in breast cancer patients. As patients with breast
cancer live longer, we may need to be more vigilant
to uncover atypical presentations of metastasis, especially those that tend to present late. At this time, the
evidence of metastasis is still less than five percent,
with many of those presenting symptomatically.6
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CONCLUSION
Currently, there is insufficient evidence to support
routine screening for bladder metastasis without
symptoms. However, the evidence is significant
enough to allow for a higher index of suspicion in
patients presenting with urinary symptoms and a
history of breast cancer to necessitate a full workup in
order to tailor treatment accordingly.
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